|
NL257307A
(cg-RX-API-DMAC10.html)
|
1959-10-28 |
|
|
|
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
|
EP1021549A2
(en)
|
1997-09-19 |
2000-07-26 |
Sequitur, Inc. |
SENSE mRNA THERAPY
|
|
EP1164125A4
(en)
|
1999-11-08 |
2005-05-04 |
Daicel Chem |
ADAMANTANE DERIVATIVES AND PROCESS FOR PREPARING
|
|
CN100523215C
(zh)
|
2000-12-01 |
2009-08-05 |
马普科技促进协会 |
介导rna干涉的小rna分子
|
|
WO2003101952A2
(en)
|
2002-05-31 |
2003-12-11 |
The Regents Of The University Of California |
Polyamine-mediated transfection
|
|
JP2005181734A
(ja)
|
2003-12-19 |
2005-07-07 |
Fuji Photo Film Co Ltd |
画像記録材料
|
|
DE102007029471A1
(de)
|
2007-06-20 |
2008-12-24 |
Novosom Ag |
Neue fakultativ kationische Sterole
|
|
EP2279254B1
(en)
|
2008-04-15 |
2017-07-05 |
Protiva Biotherapeutics Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
EP4481047A3
(en)
|
2010-06-03 |
2025-04-16 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
US9512073B2
(en)
|
2011-10-27 |
2016-12-06 |
Massachusetts Institute Of Technology |
Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
|
|
DE21212055T1
(de)
|
2011-12-07 |
2022-08-04 |
Alnylam Pharmaceuticals, Inc. |
Biologisch abbaubare lipide zur freisetzung von wirkstoffen
|
|
ES2887254T3
(es)
|
2013-03-08 |
2021-12-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
US10059655B2
(en)
|
2013-12-19 |
2018-08-28 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
US10426737B2
(en)
|
2013-12-19 |
2019-10-01 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
ES2969956T3
(es)
|
2014-09-05 |
2024-05-23 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
WO2016187531A1
(en)
|
2015-05-21 |
2016-11-24 |
Ohio State Innovation Foundation |
Benzene-1,3,5-tricarboxamide derivatives and uses thereof
|
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
|
WO2017070632A2
(en)
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
|
CN108368028B
(zh)
|
2015-10-28 |
2021-09-03 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
|
ES3030658T3
(en)
|
2016-03-30 |
2025-07-01 |
Intellia Therapeutics Inc |
Lipid nanoparticle formulations for crispr/cas components
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
RS63953B1
(sr)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
|
|
BR112019025104A2
(pt)
|
2017-05-30 |
2020-06-23 |
Glaxosmithkline Biologicals S.A. |
Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
|
|
KR102710962B1
(ko)
|
2017-07-04 |
2024-09-27 |
주식회사 인투셀 |
절단성 링커를 포함하는 화합물 및 이들의 용도
|
|
JP7449231B2
(ja)
|
2017-10-30 |
2024-03-13 |
ジョージア テック リサーチ コーポレーション |
組織送達用材料の多重化解析
|
|
US11622942B2
(en)
|
2017-11-14 |
2023-04-11 |
Ohio State Innovation Foundation |
Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof
|
|
EP3727362A4
(en)
|
2017-12-19 |
2021-10-06 |
PureTech LYT, Inc. |
MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES
|
|
CN111542338B
(zh)
|
2017-12-27 |
2024-06-18 |
武田药品工业株式会社 |
含核酸脂质纳米粒子及其用途
|
|
CN112955099B
(zh)
|
2018-07-27 |
2024-04-26 |
雷森斯医疗有限公司 |
医疗冷却装置和使用其的冷却方法
|
|
US20210300962A1
(en)
|
2018-08-02 |
2021-09-30 |
Puretech Lyt, Inc. |
Lipid prodrugs of pregnane neurosteroids and uses thereof
|
|
JP7436990B2
(ja)
|
2018-08-10 |
2024-02-22 |
国立大学法人京都大学 |
カチオン性脂質を用いた心筋細胞へのトランスフェクション方法
|
|
MX2021003455A
(es)
*
|
2018-10-02 |
2021-09-21 |
Intellia Therapeutics Inc |
Lípidos con amina ionizables.
|
|
CN119285480A
(zh)
|
2018-12-05 |
2025-01-10 |
英特利亚治疗股份有限公司 |
改性的胺脂质
|
|
EP3911302B1
(en)
|
2019-01-17 |
2025-09-10 |
Georgia Tech Research Corporation |
Drug delivery systems containing oxidized cholesterols
|
|
ES3025233T3
(en)
|
2019-01-24 |
2025-06-06 |
Agfa Nv |
Radiation curable inkjet inks for interior decoration
|
|
EP3924479A4
(en)
|
2019-02-13 |
2023-01-25 |
Beam Therapeutics, Inc. |
ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE
|
|
WO2020176868A1
(en)
|
2019-02-28 |
2020-09-03 |
Puretech Lyt, Inc. |
Lipid prodrugs of btk inhibitors and uses thereof
|
|
WO2020176856A1
(en)
|
2019-02-28 |
2020-09-03 |
Puretech Lyt, Inc. |
Lipid prodrugs of glucocorticoids and uses thereof
|
|
AU2020228662A1
(en)
|
2019-02-28 |
2021-09-09 |
Monash University |
Lipid prodrugs of JAK inhibitors and uses thereof
|
|
WO2020219876A1
(en)
*
|
2019-04-25 |
2020-10-29 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
US20220233459A1
(en)
|
2019-06-05 |
2022-07-28 |
Guide Therapeutics, Inc. |
Analysis of materials for tissue delivery
|
|
CA3143865A1
(en)
|
2019-06-07 |
2020-12-10 |
Fujifilm Corporation |
Lipid composition
|
|
EP4004207A4
(en)
|
2019-07-29 |
2023-08-23 |
Georgia Tech Research Corporation |
OLIGONUCLEOTIDE ANTAGONISTS FOR RNA-GUIDED GENO EDITING
|
|
JP7600208B2
(ja)
|
2019-07-29 |
2024-12-16 |
ジョージア テック リサーチ コーポレイション |
拘束された脂質を含むナノ材料およびその使用
|
|
JP2022552724A
(ja)
|
2019-10-21 |
2022-12-19 |
フラスクワークス, エルエルシー |
細胞培養のためのシステムおよび方法
|
|
JP7699128B2
(ja)
|
2019-12-06 |
2025-06-26 |
ガイド セラピューティクス,エルエルシー |
ナノマテリアル
|
|
CN115175894B
(zh)
*
|
2020-01-09 |
2024-09-06 |
盖德治疗有限责任公司 |
纳米材料
|
|
WO2022060871A1
(en)
*
|
2020-09-15 |
2022-03-24 |
Verve Therapeutics, Inc. |
Lipid formulations for gene editing
|
|
JP2024508347A
(ja)
|
2020-12-21 |
2024-02-27 |
ビーム セラピューティクス インク. |
エステル結合アセタールを含むナノ材料
|
|
EP4262817A4
(en)
|
2020-12-21 |
2025-03-12 |
Beam Therapeutics Inc. |
NANOMATERIALS WITH ACETALS
|
|
JP2024505327A
(ja)
|
2020-12-21 |
2024-02-06 |
ビーム セラピューティクス インク. |
炭酸塩を含むナノ材料
|
|
CN116761888A
(zh)
|
2021-01-20 |
2023-09-15 |
比姆医疗股份有限公司 |
纳米材料
|
|
CA3203741A1
(en)
|
2021-01-20 |
2022-07-28 |
Beam Therapeutics Inc. |
Nanomaterials comprising an ionizable lipid
|
|
EP4281080A4
(en)
|
2021-01-20 |
2025-09-24 |
Beam Therapeutics Inc |
NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
|
|
AU2022210299A1
(en)
|
2021-01-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable lipids for nanomaterials
|
|
JP7883580B2
(ja)
*
|
2021-10-08 |
2026-07-01 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質化合物及び脂質ナノ粒子組成物
|
|
WO2023121971A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterials comprising tetravalent lipid compounds
|
|
WO2023121965A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterial comprising diamines
|
|
WO2023121970A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine and ester lipids and lipid nanoparticles
|
|
CA3241488A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
WO2023121964A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterials comprising disulfides
|
|
EP4540222A1
(en)
|
2022-07-20 |
2025-04-23 |
Beam Therapeutics Inc. |
Nanomaterials comprising triols
|